Effect of tri-iodothyronine on normal human lymphocyte function.

Area of Science:

• Immunology
• Endocrinology
• Cell Biology

Background:

• Graves' disease is associated with immune system abnormalities.
• Elevated thyroid hormone levels, specifically tri-iodothyronine (T3), are common in Graves' disease.
• The direct impact of hyperthyroidism on lymphocyte function requires clarification.

Purpose of the Study:

• To investigate the in vivo effects of excessive tri-iodothyronine (T3) on normal human lymphocyte function.
• To determine if elevated T3 levels contribute to immunological abnormalities observed in Graves' disease.
• To differentiate between the restoration of euthyroidism and drug-induced immunosuppression in disease remission.

Main Methods:

• Human lymphocytes were isolated from normal subjects before and after a 1-week course of oral T3 administration.
• Cells were cryopreserved for direct comparison under identical culture conditions.
• Lymphocyte subsets, T and B cell activation (via phytohaemagglutinin and pokeweed mitogen stimulation), and in vitro T3 supplementation effects were assessed.

Main Results:

• While some individuals exhibited changes in B or T cell function, hyperthyroidism did not produce consistent group-wide effects on circulating T cell subsets.
• No consistent impact of elevated T3 was observed on T and B cell activation.
• In vitro T3 supplementation did not alter pokeweed mitogen-stimulated lymphocyte activation.

Conclusions:

• The immunological abnormalities in Graves' disease are unlikely to be solely caused by increased circulating thyroid hormone levels.
• Remission of Graves' disease following medical treatment may be attributed to the immunosuppressive effects of the medication rather than solely the restoration of normal thyroid hormone levels (euthyroidism).
• This study suggests a dissociation between thyroid hormone levels and immune cell function in the context of Graves' disease.